Enhanced OCT4 transcriptional activity substitutes for exogenous SOX2 in cellular reprogramming

被引:7
|
作者
Marthaler, Adele G. [1 ]
Adachi, Kenjiro [1 ]
Tiemann, Ulf [2 ]
Wu, Guangming [1 ]
Sabour, Davood [1 ]
Velychko, Sergiy [1 ]
Kleiter, Ingo [3 ]
Schoeler, Hans R. [1 ,4 ]
Tapia, Natalia [1 ,2 ]
机构
[1] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, Germany
[2] Univ Dusseldorf, Fac Med, D-40225 Dusseldorf, Germany
[3] Ruhr Univ Bochum, St Josef Hosp, Dept Neurol, D-44791 Bochum, Germany
[4] Univ Munster, Fac Med, D-48149 Munster, Germany
来源
SCIENTIFIC REPORTS | 2016年 / 6卷
关键词
EXPRESSION; MOUSE; DIFFERENTIATION; KLF4;
D O I
10.1038/srep19415
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Adenoviral early region 1A (E1A) is a viral gene that can promote cellular proliferation and dedifferentiation in mammalian cells, features required for the reprogramming of somatic cells to a pluripotent state. E1A has been shown to interact with OCT4, and as a consequence, to increase OCT4 transcriptional activity. Indeed, E1A and OCT4 are sufficient to revert neuroepithelial hybrids to pluripotency, as demonstrated in previous cell fusion experiments. However, the role that E1A might play in the generation of induced pluripotent stem cells (iPSCs) has not been investigated yet. In this report, we show that E1A can generate iPSCs in combination with OCT4 and KLF4, thus replacing exogenous SOX2. The generated iPSCs are bona fide pluripotent cells as shown by in vitro and in vivo tests. Overall, our study suggests that E1A might replace SOX2 through enhancing OCT4 transcriptional activity at the early stages of reprogramming.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Interaction of Sox1, Sox2, Sox3 and Oct4 during primary neurogenesis
    Archer, Tenley C.
    Jin, Jing
    Casey, Elena S.
    [J]. DEVELOPMENTAL BIOLOGY, 2011, 350 (02) : 429 - 440
  • [32] Zfp206, Oct4, and Sox2 Are Integrated Components of a Transcriptional Regulatory Network in Embryonic Stem Cells
    Yu, Hong-bing
    Kunarso, Galih
    Hong, Felicia Huimei
    Stanton, Lawrence W.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (45) : 31327 - 31335
  • [33] Rapid and efficient reprogramming of human amnion-derived cells into pluripotency by three factors OCT4/SOX2/NANOG
    Zhao, H.
    Li, Y.
    Haifeng, J.
    Xie, L.
    Chuang, L.
    Feng, J.
    Yaning, L.
    Guowu, Y.
    Yi, L.
    Jun, W.
    Xiaohong, W.
    [J]. HUMAN REPRODUCTION, 2010, 25 : I339 - I339
  • [34] Enrichment of the embryonic stem cell reprogramming factors Oct4, Nanog, Myc, and Sox2 in benign and malignant vascular tumors
    Amaya, Clarissa N.
    Bryan, Brad A.
    [J]. BMC CLINICAL PATHOLOGY, 2015, 15
  • [35] Rapid and efficient reprogramming of human amnion-derived cells into pluripotency by three factors OCT4/SOX2/NANOG
    Zhao, Hong-xi
    Li, Yang
    Jin, Hai-feng
    Xie, Li
    Liu, Chuang
    Jiang, Feng
    Luo, Ya-ning
    Yin, Guo-wu
    Li, Yi
    Wang, Jun
    Li, Ling-song
    Yao, Yuan-qing
    Wang, Xiao-hong
    [J]. DIFFERENTIATION, 2010, 80 (2-3) : 123 - 129
  • [36] Endogenous fluctuations of OCT4 and SOX2 bias pluripotent cell fate decisions
    Strebinger, Daniel
    Deluz, Cedric
    Friman, Elias T.
    Govindan, Subashika
    Alber, Andrea B.
    Suter, David M.
    [J]. MOLECULAR SYSTEMS BIOLOGY, 2019, 15 (09)
  • [37] Sox2/Oct4: A delicately balanced partnership in pluripotent stem cells and embryogenesis
    Rizzino, Angie
    Wuebben, Erin L.
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS, 2016, 1859 (06): : 780 - 791
  • [38] Endogenous fluctuations of OCT4 and SOX2 bias pluripotent cell fate decisions
    Strebinger, D.
    Friman, E. T.
    Deluz, C.
    Govindan, S.
    Alber, A. B.
    Suter, D. M.
    [J]. HUMAN GENE THERAPY, 2018, 29 (12) : A150 - A150
  • [39] The Dyskerin Ribonucleoprotein Complex as an OCT4/SOX2 Coactivator in Embryonic Stem Cells
    Fong, Yick W.
    Ho, Jaclyn J.
    Inouye, Carla
    Tjian, Robert
    [J]. ELIFE, 2014, 3
  • [40] SOX2 and OCT4 mediate radiation and drug resistance in pancreatic tumor organoids
    Roy, Sanjit
    Dukic, Tijana
    Keepers, Zachery
    Bhandary, Binny
    Lamichhane, Narottam
    Molitoris, Jason
    Ko, Young H.
    Banerjee, Aditi
    Shukla, Hem D.
    [J]. CELL DEATH DISCOVERY, 2024, 10 (01)